Artwork

Content provided by The Lancet and The Lancet Haematology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet and The Lancet Haematology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

In conversation with... Kim Linton

9:48
 
Share
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 22, 2024 01:08 (29d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 433036165 series 3381973
Content provided by The Lancet and The Lancet Haematology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet and The Lancet Haematology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.

  continue reading

49 episodes

Artwork
iconShare
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 22, 2024 01:08 (29d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 433036165 series 3381973
Content provided by The Lancet and The Lancet Haematology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet and The Lancet Haematology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.

  continue reading

49 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide